MENU
+Compare
DGNOF
Stock ticker: OTC
AS OF
Sep 26 closing price
Price
$0.19
Change
+$0.01 (+5.56%)
Capitalization
19.36M

DGNOF Diagnos Inc. Forecast, Technical & Fundamental Analysis

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy... Show more

DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DGNOF with price predictions
Sep 26, 2025

DGNOF in upward trend: price rose above 50-day moving average on September 26, 2025

DGNOF moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend. In of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where DGNOF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 25, 2025. You may want to consider a long position or call options on DGNOF as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DGNOF advanced for three days, in of 87 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGNOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DGNOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DGNOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (108.696) is normal, around the industry mean (21.716). P/E Ratio (0.000) is within average values for comparable stocks, (84.593). DGNOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.871). DGNOF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (277.778) is also within normal values, averaging (68.588).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
7005 Taschereau Boulevard
Phone
+1 450 678-8882
Employees
42800
Web
http://www.diagnos.ca
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEFDF0.53N/A
N/A
DELFI LTD
SODI16.75N/A
N/A
Solitron Devices, Inc.
YAMCF6.66N/A
N/A
Yamaha Corp.
WPLCF14.44-0.06
-0.45%
WISE PLC
PLSH0.06-0.01
-13.64%
Panacea Life Sciences Holdings, Inc.

DGNOF and Stocks

Correlation & Price change

A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
+1.92%
KNAMF - DGNOF
27%
Poorly correlated
N/A
NEXOY - DGNOF
25%
Poorly correlated
+1.52%
DTSS - DGNOF
24%
Poorly correlated
-10.17%
ELWS - DGNOF
22%
Poorly correlated
+8.47%
AGYS - DGNOF
22%
Poorly correlated
+1.34%
More

Groups containing DGNOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
+1.92%
Health Services
category (437 stocks)
4%
Poorly correlated
+0.41%
Services to the Health Industry
category (94 stocks)
-2%
Poorly correlated
+1.05%